Nordlys is a next-generation light-based treatment device developed by Ellipse in Denmark and currently sold by Cynosure. It is based on IPL, which delivers a broad range of wavelengths of light at once, while incorporating the more advanced I2PL technology. A distinctive feature is its structure, in which a water filter inside the applicator removes wavelengths below 400 nm and above 950 nm in advance—wavelengths that are more likely to cause burns and post-inflammatory hyperpigmentation.
Another notable feature is that it does not require a cooling device. Cooling causes blood vessels to constrict, which had been one factor that weakened the effects of treatment for facial redness. Because Nordlys can irradiate the skin while the blood vessels remain dilated, it can be considered well suited to addressing redness.
As an IPL (Intense Pulsed Light) device, it is the only IPL light-based treatment device in Japan as of June 2026 to have obtained Japan’s first regulatory approval for three indications: pigmented skin conditions, vascular lesions, and long-term hair reduction. For more information about Nordlys, please also refer to the article below.